3 completed, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow ioflupane: new trials by email Literature Review of ioflupane trials Research Report on ioflupane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls (11C)PE2I, Ioflupane - Parkinson Disease, REM Sleep Behavior Disorder | Phase 1 / Phase 2 | Completed | Weill Medical College of Cornell University | 82 | 2018-08-14 | 2025-03-12 |
| Diagnostic Imaging for Clear Cell Renal Cell Carcinoma Ioflupane I123 - Clear Cell Renal Cell Carcinoma | Phase 2 | Terminated | Region Skane | 5 | 2017-07-14 | 2019-06-21 |
| Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression DaTscan - Parkinson Disease | Phase 2 | Completed | Ken Marek, MD | 952 | 2010-06-01 | 2023-11-14 |
| Dopaminergic Loss and Pain in Parkinson's Disease ioflupane 123I (DATSCANĀ®) - Parkinson's Disease, Pain | Phase 2 | Completed | University Hospital, Toulouse | 20 | 2009-03-01 | 2020-07-29 |
Parkinson Disease (3) · Carcinoma, Renal Cell (1) · Disease (1) · Neurodegenerative Diseases (1) · Pain (1) · REM Sleep Behavior Disorder (1)
Ken Marek, MD (1) · Region Skane (1) · University Hospital, Toulouse (1) · Weill Medical College of Cornell University (1)
France (2) · United States (2) · Australia (1) · Austria (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Norway (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Alexander Shtilbans, MD (1) · Andrew Singleton, PhD (1) · Arthur W. Toga, PhD (1) · Christine Brefel-Courbon, MD (1) · Christopher Coffey, PhD (1) · John P Seibyl, MD (1) · John Q. Trojanowski, MD, PhD (1) · Karl Kieburtz, MD (1) · Kenneth L Marek, MD (1) · Peter Elfving, M.D. PhD (1) · Tatiana Froud, PhD (1)
PMID 25710187, PMID 26534930, PMID 28958801, PMID 28986467, PMID 30706197, PMID 31678032, PMID 32073681, PMID 33790041, PMID 36849448, PMID 37332638, PMID 37451695, PMID 37491235, PMID 37586882, PMID 38169864, PMID 39043465, PMID 39627057, PMID 39644799, PMID 40164470, PMID 40705614, PMID 41094519, PMID 41453126, PMID 42393590
2016 (1), R01NS095562 (1)